|Articles|March 1, 2002
- Applied Clinical Trials-03-01-2002
Selecting Sites and Investigators
The system is an important part of the selection equation in CEE nations where sponsors must contract with institutions rather than investigators. Examples from Hungary offer guidelines for improving selection SOPs.
Advertisement
Articles in this issue
over 23 years ago
Consider Geography When Choosing Investigative Sitesover 23 years ago
Meet the Editorial Advisory Board Francis Crawleyover 23 years ago
9th ACT European Summitover 23 years ago
Letters to the Editorover 23 years ago
Safety and Risk Assessment Gain Importanceover 23 years ago
Transporting Clinical Trial Samplesover 23 years ago
Forward to 2004 or Back to 1984?Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Reimagining Clinical Operations Through Artificial Intelligence
2
Integrating AI Across Legacy Clinical Trial Systems
3
Preparation Tips to Minimize Impact of Regulatory Inspections for IRT Systems
4
Balancing Human Oversight and Automation in AI-Driven Trials
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
